ANKRD49 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.436000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.896800E-01
Normal-vs-Stage2
3.478200E-01
Normal-vs-Stage3
2.538600E-01
Normal-vs-Stage4
2.315000E-01
Stage1-vs-Stage2
5.868400E-01
Stage1-vs-Stage3
9.166000E-02
Stage1-vs-Stage4
7.474000E-01
Stage2-vs-Stage3
1.203220E-01
Stage2-vs-Stage4
9.956800E-01
Stage3-vs-Stage4
2.273400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.413000E-01
Normal-vs-AfricanAmerican
2.268400E-01
Normal-vs-Asian
3.451400E-01
Caucasian-vs-AfricanAmerican
5.537200E-01
Caucasian-vs-Asian
9.914600E-01
AfricanAmerican-vs-Asian
5.195000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.367800E-01
Normal-vs-Female
3.537800E-01
Male-vs-Female
4.300800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.099800E-01
Normal-vs-Age(41-60Yrs)
3.768400E-01
Normal-vs-Age(61-80Yrs)
3.323600E-01
Normal-vs-Age(81-100Yrs)
3.209400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.781000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.854400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.806200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.006100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.009980E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.632600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.228000E-01
Normal-vs-Daily Drinker
3.505600E-01
Normal-vs-Weekly Drinker
2.985800E-01
Normal-vs-Occasional Drinker
3.466600E-01
Normal-vs-Social Drinker
3.575200E-01
Non Drinker-vs-Daily Drinker
5.117000E-01
Non Drinker-vs-Weekly Drinker
4.833600E-01
Non Drinker-vs-Occasional Drinker
4.813800E-01
Non Drinker-vs-Social Drinker
3.637000E-01
Daily Drinker-vs-Weekly Drinker
3.073400E-01
Daily Drinker-vs-Occasional Drinker
9.559000E-01
Daily Drinker-vs-Social Drinker
8.786600E-01
Weekly Drinker-vs-Occasional Drinker
2.205800E-01
Weekly Drinker-vs-Social Drinker
1.852200E-01
Occasional Drinker-vs-Social Drinker
7.893400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.181900E-02
Normal-vs-Grade 2
7.343100E-03
Normal-vs-Grade 3
1.634080E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.490800E-01
Grade 1-vs-Grade 3
7.242400E-01
Grade 1-vs-Grade 4
8.181900E-02
Grade 2-vs-Grade 3
7.902800E-01
Grade 2-vs-Grade 4
7.343100E-03
Grade 3-vs-Grade 4
1.634080E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.112000E-01
Normal-vs-NonDiabetic
3.408200E-01
Diabetic-vs-NonDiabetic
1.666830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.842000E-01
Normal-vs-NoPancreatitis
3.275600E-01
Pancreatitis-vs-NoPancreatitis
1.920840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.571600E-01
Normal-vs-N1
3.391800E-01
N0-vs-N1
4.716600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.222600E-01
Normal-vs-TP53-NonMutant
4.012000E-01
TP53-Mutant-vs-TP53-NonMutant
5.624800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
